Patent classifications
C07F5/022
Electrolyte composition and metal-ion battery employing the same
An electrolyte composition and a metal-ion battery employing the same are provided. The electrolyte composition includes a metal chloride, an imidazolium salt of Formula (I), an alkali halide, and an oxalate-containing borate ##STR00001##
wherein R.sup.1, R.sup.2, and R.sup.3 are independently C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.1-8 alkoxy, C.sub.2-8 alkoxyalkyl, or C.sub.1-8 fluoroalkyl; and X.sup.− is F.sup.−, Cl.sup.−, Br.sup.−, or I.sup.−. The metal chloride is aluminum chloride, iron chloride, zinc chloride, copper chloride, manganese chloride, chromium chloride, or a combination thereof.
ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE
An organic compound and an electronic device, the organic compound being represented by General Formula (1):
##STR00001## wherein, in General Formula (1), R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are each independently a substituted or unsubstituted alkyl group having 1 to 4 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 4 carbon atoms, or a substituted or unsubstituted alkylthio group having 1 to 4 carbon atoms, A.sup.1 and A.sup.2 are each independently hydrogen, an aryl group including a ring that includes at least six members, or a heteroaryl group including a ring that includes at least five members, at least one of A.sup.1 and A.sup.2 being an aryl group including a ring that includes at least six members or a heteroaryl group including a ring that includes at least five members, and A.sup.3 is an aryl group including a ring that includes at least six members or a heteroaryl group including a ring that includes at least five members.
Sulfur-containing additives for electrochemical or optoelectronic devices
The invention relates to sulfur-containing compounds of the formula I, to their preparation, and to their use as additives in electrochemical or electrooptical devices, more particularly in electrolytes for lithium batteries, lithium ion batteries, double layer capacitors, lithium ion capacitors, solar cells, electrochromic displays, sensors and/or biosensors.
Biocompatible modular tetrazine platform
A modular tetrazine platform, can be used as diagnostic, theragnostic agent and/or medicinal product. An inverse electron demand Diels-Alder reaction can be used for synthesizing bifunctionalized tetrazines, which can be obtained from monofunctionalised tetrazines.
NOVEL SMALL MOLECULE ANTICANCER AGENTS
The invention relates to methods of treating cell proliferative disorders. The invention further relates to pharmaceutical compositions for treating cell proliferative disorders, especially cancer.
Curcumin analogs
Provided herein are curcumin analogues that are able to interact with amyloid β (Aβ) and to attenuate the copper-induced crosslinking of Aβ. Also provided herein are methods of using the compounds in the treatment of Alzheimer's Disease or a related disorder.
DERIVATIVES OF BODIPY
Derivatives of BODIPY with improved properties (such as longer Stokes shift relative to existing fluorophores) are disclosed.
Protective groups and methods for protecting benzoxaboroles or oxaboroles
The present invention relates in part to protective groups that can be used to reversibly protect benzoxaboroles and/or oxaboroles and yield the corresponding protected complexes. The invention further relates to the use of these protective groups to protect benzoxaboroles and/or oxaboroles.
Functionalized choline chloride ionic liquid, preparation method thereof and use in electrochemical energy storage device
The present invention discloses a process for preparing a functionalized choline chloride ionic liquid as defined in formula (I), and thereof use in an electrochemical energy storage device, as an electrolyte solution or an additive for a lithium ion battery and a supercapacitor. The ionic liquid electrolyte material has better biocompatibility, flame retardance, high ionic conductivity, low viscosity, and wide electrochemical window. ##STR00001## wherein R.sup.1 is selected from the group consisting of: (CH.sub.2═CH—(CH.sub.2).sub.n)—, CN(CH.sub.2).sub.n—, or R.sup.2.sub.3Si—; R.sup.2 is selected from CH.sub.3—(CH.sub.2).sub.m—, n is an integer selected from 1 to 3, m is an integer selected from 0 to 2; or one of R.sup.2 is (CH.sub.3).sub.3Si—O—. Anion A in Formula I is selected from the group consisting of: Cl.sup.−, Br.sup.−, I.sup.−, BF.sub.4.sup.−, NO.sub.3.sup.−, SO.sub.4.sup.2−, CF.sub.3COO.sup.−, CF.sub.3SO.sub.3.sup.−, (CF.sub.3SO.sub.2).sub.2N.sup.−, PF.sub.6.sup.−, BF.sub.2C.sub.2O.sub.4.sup.−, or B(C.sub.2O.sub.4).sub.2.sup.−.